The history of copyright's flagship drug presents a interesting case for investors in the drug sector. While initially a tremendous success, producing vast sums, the intellectual property lapse and the subsequent entry of cheaper alternatives have significantly changed revenue. This raises questions about the future profitability of related drug… Read More